porno izle
women desperate to piss ava addams mom porn sa akin ang gabi

OBN is the not-for-profit Membership organisation supporting and bringing together the UK’s life sciences companies, corporate partners and investors. Our 400-plus Member companies are located across the Golden Triangle and beyond to Manchester, Nottingham, the Midlands, South Coast and Scotland,  benefiting from our networking, partnering, purchasing, training, advising and advocacy activities. China France Germany Italy Japan Poland Portugal Spain


BioSeed 2021
OBN Awards 2020
OBN Membership Pack
BioForward 2021
OBN Purchasing Platform
OBN Membership Pack
OBN Membership Pack
OBN ITSIG version 2

OBN's COVID-19 Forum

Share your news and comment via @CovidObn

OBN Patrons


OBN Sponsors


Sr LIMS Developer

Company Description We are a leader in liquid biopsy. Every day we transform the lives of cancer patients and their families through the power of liquid biopsy. Our tests unlock essential genomic information...

Read more

Target Validation Lead

We are looking for an innovative and enthusiastic Target Validation expert to advance our efforts in validating the expression of novel immunotherapy targets across a range of primary samples and model...

Read more

In Vivo Pharmacology Lead

Enara Bio is seeking a highly motivated, experienced, and creative individual with expertise in cancer immunology and cell therapy to be a key driver in our preclinical research efforts to advance our...

Read more

RSSL Technician - Microscopy

This exciting yet challenging role as a RSSL Technician will involve performing all stages of routine testing to support Microscopy’s foreign body identification service and food R&D business. The role...

Read more

OBN: Part-time Executive Chair of OBN

As part of the organisation’s development, we are seeking to appoint an experienced Executive Chair with the required sector experience and gravitas to provide effective support to the CEO and direction...

Read more
Read More Jobs


Immunocore announces closing of $75.0 Million Series C round

20 January 2021

Immunocore, a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer...

Read more

Inivata’s First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

20 January 2021

Inivata, a leader in liquid biopsy, today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by the European Organisation for...

Read more

AMSBIO: Cell Free Nucleic Acid Extraction

19 January 2021

The cfPure® Cell Free DNA Extraction Kit from AMSBIO is a magnetic bead-based DNA extraction kit designed to isolate circulating cell free DNA (cfDNA) from human plasma or serum samples.

Read more

Yourgene Health: Clarigene® SARS-CoV-2 Product Update and Partnerships with CityDoc and ReCoVa-19

18 January 2021

Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that following the Company’s statement on 24 December 2020, regarding the new virus strain (VUI202012/01 SARS-CoV-2 variant...

Read more
Read More News


Read More Events

OBN Supporters

Investor Supporters

Silicon Valley Bank


Collaborators and Accreditations

BioHub Birmingham
Innovate UK